Cargando…
Genetic heterogeneity in breast cancer: the road to personalized medicine?
More women die from breast cancer across the world today than from any other type of malignancy. The clinical course of breast cancer varies tremendously between patients. While some of this variability is explained by traditional clinico-pathological factors (including patient age, tumor stage, his...
Autores principales: | Baird, Richard D, Caldas, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689054/ https://www.ncbi.nlm.nih.gov/pubmed/23800221 http://dx.doi.org/10.1186/1741-7015-11-151 |
Ejemplares similares
-
Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013) -
Reasons for breast cancer heterogeneity
por: Bertucci, François, et al.
Publicado: (2008) -
Genetic heterogeneity of colorectal cancer and the microbiome
por: Senchukova, Marina A
Publicado: (2023) -
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
por: Gerlinger, M, et al.
Publicado: (2010) -
Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
por: Lin, Miranda, et al.
Publicado: (2019)